Summary
This business focuses on developing innovative immunology solutions aimed at improving the lives of patients with severe autoimmune diseases. It operates by creating a collaborative ecosystem that brings together scientists and antibody engineers to accelerate the discovery of novel therapeutic antibodies. The company emphasizes the importance of co-creation and partnership in its research and development efforts, with a proprietary portfolio of first-in-class product candidates designed to address unmet medical needs.
8 of 8 checks passed
Label
Value
Active Dates
13.9 years — Since Feb 2011
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
325414
SIC 4 Digit Code
2836
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Microsoft
TXT Record
Apple
TXT Record
Atlassian
TXT Record
DocuSign
TXT Record
GlobalSign
TXT Record
TXT Record
MongoDB
TXT Record
OneTrust
TXT Record
Smartsheet
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|